跳至主要内容
临床试验/JPRN-UMIN000003034
JPRN-UMIN000003034已完成未知

High-dose intravenous immunoglobulin therapy for refractory viral infection after allogeneic hematopoietic stem cell transplantation. - High-dose intravenous immunoglobulin therapy for refractory viral infection after allogeneic hematopoietic stem cell transplantation.

Hematology, Osaka City University, Graduate School of Meicine0 个研究点目标入组 14 人开始时间: 2010年1月14日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of allergic reaction to immunoglobulin preparations 2) History of severe adverse effect of immunoglobulin preparations 3) Presence of veno-occlusive disease (VOD) after allogeneic stem cell transplantation 4) Positivity of HIV-antibody, HCV-antibody, HBs-antigen, or HBV-DNA 5) No indication for this study judged by physician in charge

研究者

发起方
Hematology, Osaka City University, Graduate School of Meicine

相似试验